Jin Medical International Ltd. (ZJYL) | Investment Case

1. Company Snapshot

1.a. Company Description

Jin Medical International Ltd.engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally.It also offers oxygen concentrators and bathing machines.

The company was founded in 2006 and is based in Changzhou, China.Jin Medical International Ltd.is a subsidiary of Jolly Harmony Enterprises Limited.

Show Full description

1.b. Last Insights on ZJYL

Jin Medical International Ltd.'s recent performance was negatively impacted by the company's inability to sustain its momentum, despite the initiation of construction on its new manufacturing facility in Chuzhou, China. The facility's higher-level production lines are expected to strengthen JinMed's leadership in the assistive technologies industry, but this development has not yet translated to improved financials.

1.c. Company Highlights

Last Price	0.24
Change Percentage	1.97%
Open	0.24
Previous Close	0.23
Market Cap ( Millions)	37
Volume	68772
Year High	1.42
Year Low	0.21
M A 50	0.34
M A 200	0.62

FCF Yield	-2.17%
Dividend Yield	0.00%
ROE	6.32%
Debt / Equity	57.02%
Net Debt / EBIDTA	217.04%
Price To Book	1.33
Price Earnings Ratio	20.78
Price To FCF	-46.07
Price To sales	1.63
EV / EBITDA	19.05

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Jin Medical International (NASDAQ:ZJYL) Trading Down 4.6% – Should You Sell?

Nov -22

Source: defenseworld.net

Jin Medical International Ltd. (NASDAQ:ZJYL) Short Interest Up 72.3% in September

Oct -22

Source: defenseworld.net

Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility

Jul -16

Source: globenewswire.com

Jin Medical International Ltd. – Nasdaq Minimum Bid Price Non-Compliance

May -06

Source: globenewswire.com

Construction of JinMed's New Facility Begins in Chuzhou, China

Oct -10

Source: globenewswire.com

ZJYL Sees a Stock Surge of 5.04% Amid Positive Financial Performance

Oct -02

Source: gurufocus.com

JetBlue Airways, B. Riley Financial, Hawaiian Electric And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Aug -12

Source: benzinga.com

Why Is Jin Medical International (ZJYL) Stock Moving Today?

Feb -08

Source: InvestorPlace

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (4.80%)

6. Segments

Wheelchair

Expected Growth: 4.8%

Growing demand for mobility aids, increasing elderly population, and advancements in wheelchair technology drive the market growth. The lightweight and adjustable design of Jin Medical's wheelchair caters to the comfort and independence needs of users, contributing to the segment's growth.

Wheelchair Components and Others

Expected Growth: 4.8%

Growing demand for mobility aids, increasing elderly population, and advancements in wheelchair technology drive the growth of wheelchair components and accessories market.

7. Detailed Products

Orthopedic Implants

Jin Medical International Ltd. offers a wide range of orthopedic implants, including hip and knee replacements, spinal implants, and trauma devices.

Surgical Instruments

The company provides a comprehensive range of surgical instruments, including forceps, scissors, retractors, and more.

Wound Care Products

Jin Medical International Ltd. offers a variety of wound care products, including dressings, bandages, and topical treatments.

Dental Implants

The company provides dental implants, including titanium implants and abutments, for oral rehabilitation.

Medical Disposables

Jin Medical International Ltd. offers a range of medical disposables, including syringes, needles, and medical gloves.

Ophthalmic Products

The company provides ophthalmic products, including intraocular lenses, viscoelastic agents, and surgical instruments.

8. Jin Medical International Ltd.'s Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes is moderate due to the availability of alternative medical services and products in the market.

Bargaining Power Of Customers

The bargaining power of customers is low due to the specialized nature of Jin Medical International Ltd.'s services and products.

Bargaining Power Of Suppliers

The bargaining power of suppliers is moderate due to the presence of multiple suppliers in the market, but Jin Medical International Ltd.'s dependence on a few key suppliers.

Threat Of New Entrants

The threat of new entrants is high due to the growing demand for medical services and products, and the relatively low barriers to entry in the market.

Intensity Of Rivalry

The intensity of rivalry is high due to the presence of several established players in the market, and the need for Jin Medical International Ltd. to differentiate itself through innovative products and services.

9. SWOT Analysis

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

	Value
Debt Weight	14.64%
Debt Cost	3.95%
Equity Weight	85.36%
Equity Cost	107.24%
WACC	92.12%
Leverage	17.15%

11. Quality Control: Jin Medical International Ltd. passed 6 out of 9 key points

Strong Liquidity

Low Debt

Strong Interest Coverage

Healthy Cash Flow

Operating Efficiency

Strong Return On Equity

Consistent Revenue Growth

Consistent Operating Cash Flow Growth

Margin Improvement

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Meihua Medical

A-Score: 4.6/10

Value: 10.0

Growth: 4.9

Quality: 7.5

Yield: 0.0

Momentum: 1.5

Volatility: 3.7

1-Year Total Return ->

Jin Medical International

A-Score: 3.7/10

Value: 3.8

Growth: 6.6

Quality: 5.8

Yield: 0.0

Momentum: 3.5

Volatility: 2.7

1-Year Total Return ->

Tecan

A-Score: 3.6/10

Value: 4.4

Growth: 4.1

Quality: 5.7

Yield: 2.5

Momentum: 0.0

Volatility: 4.7

1-Year Total Return ->

Carl Zeiss Meditec

A-Score: 3.3/10

Value: 3.9

Growth: 5.0

Quality: 5.9

Yield: 1.9

Momentum: 1.0

Volatility: 2.3

1-Year Total Return ->

Repligen

A-Score: 3.0/10

Value: 0.2

Growth: 5.0

Quality: 3.9

Yield: 0.0

Momentum: 5.0

Volatility: 3.7

1-Year Total Return ->

Cooper

A-Score: 2.9/10

Value: 2.9

Growth: 1.2

Quality: 5.9

Yield: 0.0

Momentum: 1.0

Volatility: 6.3

1-Year Total Return ->

Peers Metrics

12.e Scoring ^Insights

12.f DCF ^BETA

Parameters

Short Term Growth

100.00%

Short term Time

10.0

Long-Term Growth

2.00%

WACC

92.12%

Jin Medical International Ltd. - KYG5140V1124

1. Company Snapshot

1.a. Company Description

1.b. Last Insights on ZJYL

1.c. Company Highlights

Expensive

Better Quality

Strong Momentum

Higher Growth

Medium Volatility

More Volatile

Weak Momentum

Average Quality

Stable Momentum

2. Transcript Summary

3. NewsRoom

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (4.80%)

6. Segments

Wheelchair

Expected Growth: 4.8%

Wheelchair Components and Others

Expected Growth: 4.8%

7. Detailed Products

Orthopedic Implants

Surgical Instruments

Wound Care Products

Dental Implants

Medical Disposables

Ophthalmic Products

8. Jin Medical International Ltd.'s Porter Forces

Forces Ranking

Threat Of Substitutes

Bargaining Power Of Customers

Bargaining Power Of Suppliers

Threat Of New Entrants

Intensity Of Rivalry

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

11. Quality Control: Jin Medical International Ltd. passed 6 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

0.03$

Current Price

0.24$

Potential

-86.09%

Expected Cash-Flows

12.e Scoring ^Insights

12.f DCF ^BETA